AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 14.60
-0.10 (-0.68%)
Jan 22, 2026, 1:30 PM CST
AmCad BioMed Company Description
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan.
It offers products for early detection and diagnosis of various diseases. The company’s products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients.
It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection.
The company was incorporated in 2008 and is based in Taipei City, Taiwan.
AmCad BioMed Corporation
| Country | Taiwan |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 34 |
| CEO | Yi-Li Lee |
Contact Details
Address: No. 167 Fuxing North Road Taipei, 104 Taiwan | |
| Phone | 886 2 2713 6227 |
| Website | amcad.com.tw |
Stock Details
| Ticker Symbol | 4188 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004188008 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Yi-Li Lee | Chairman, President and Manager |
| Ann Chen | Financial Officer |
| Zhao Ming Chen | Accounting Supervisor |
| Zhenggang Chen | Chief Research & Development Officer |